Garenoxacin (BMS-284756) and Moxifloxacin in Experimental Meningitis Caused by Vancomycin-Tolerant Pneumococci

The emergence of multidrug-resistant strains of Streptococcus pneumoniae drives the development and evaluation of new antipneumococcal agents, especially for the treatment of bacterial meningitis. The aims of the present study were to assess the antibacterial effectiveness of two new quinolones, gar...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Rodriguez-Cerrato, Violeta, McCoig, Cindy C., Saavedra, Jesus, Barton, Tess, Michelow, Ian C., Hardy, Robert D., Bowlware, Karen, Iglehart, Janie, Katz, Kathy, McCracken, George H.
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 2003
Schlagworte:	Experimental Therapeutics
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC148949/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12499193/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.1.211-215.2003
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!